Literature DB >> 16009279

Multiplex PCR for screening of integrons in bacterial lysates.

B Dillon1, L Thomas, G Mohmand, A Zelynski, J Iredell.   

Abstract

Bacterial integrons are a useful PCR amplification target in epidemiological surveys of bacterial antibiotic resistance, and a variety of primers have been published. We describe multiplex PCR methodology to test for classes 1, 2 and 3 integron-associated integrases in boiled lysates of Gram-negative bacteria. We report on performance in Acinetobacter spp. (n=50), Enterobacteriaceae (n=76), Pseudomonas aeruginosa (n=15), Bacteroidesspp. (n=69), and in undifferentiated mixed cultures derived from perineal swabs (n=50) and endotracheal aspirates (n=8). This method achieved 100% sensitivity and specificity in simple lysates made from a range of bacteria, without requiring DNA extraction, and is recommended as an efficient screening tool for surveys of integron cassettes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009279     DOI: 10.1016/j.mimet.2005.02.007

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  23 in total

1.  Genotyping and molecular characterization of clinical Acinetobacter baumannii isolates from a single hospital in Southwestern Iran.

Authors:  Ahmad Farajzadeh Sheikh; Mohammad Savari; Effat Abbasi Montazeri; Saeed Khoshnood
Journal:  Pathog Glob Health       Date:  2020-06-19       Impact factor: 2.894

2.  Worldwide prevalence of class 2 integrases outside the clinical setting is associated with human impact.

Authors:  Carlos M Rodríguez-Minguela; Juha H A Apajalahti; Benli Chai; James R Cole; James M Tiedje
Journal:  Appl Environ Microbiol       Date:  2009-06-05       Impact factor: 4.792

3.  A novel gene cassette, aacA43, in a plasmid-borne class 1 integron.

Authors:  Sally R Partridge; Lee C Thomas; Andrew N Ginn; Agnieszka M Wiklendt; Pierre Kyme; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

4.  Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria.

Authors:  Olumuyiwa Samuel Alabi; Nuno Mendonça; Olufemi Ezekiel Adeleke; Gabriela Jorge da Silva
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

5.  Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii.

Authors:  Jubelle K Valenzuela; Lee Thomas; Sally R Partridge; Tanny van der Reijden; Lenie Dijkshoorn; Jon Iredell
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

6.  Phylogenetic groups, virulence genes and quinolone resistance of integron-bearing Escherichia coli strains isolated from a wastewater treatment plant.

Authors:  Joanna Mokracka; Ryszard Koczura; Lucyna Jabłońska; Adam Kaznowski
Journal:  Antonie Van Leeuwenhoek       Date:  2011-02-04       Impact factor: 2.271

7.  Transferable integrons of Gram-negative bacteria isolated from the gut of a wild boar in the buffer zone of a national park.

Authors:  Joanna Mokracka; Ryszard Koczura; Adam Kaznowski
Journal:  Ann Microbiol       Date:  2011-10-21       Impact factor: 2.112

8.  Molecular characterization of a 21.4 kilobase antibiotic resistance plasmid from an α-hemolytic Escherichia coli O108:H- human clinical isolate.

Authors:  Fay E Dawes; Dieter M Bulach; Alexander Kuzevski; Karl A Bettelheim; Carola Venturini; Steven P Djordjevic; Mark J Walker
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

9.  Association between the presence of class 1 integrons, virulence genes, and phylogenetic groups of Escherichia coli isolates from river water.

Authors:  Ryszard Koczura; Joanna Mokracka; Agata Barczak; Natalia Krysiak; Adam Kaznowski
Journal:  Microb Ecol       Date:  2012-08-19       Impact factor: 4.552

10.  Increased frequency of integrons and β-lactamase-coding genes among extraintestinal Escherichia coli isolated with a 7-year interval.

Authors:  Joanna Mokracka; Anna Oszyńska; Adam Kaznowski
Journal:  Antonie Van Leeuwenhoek       Date:  2012-09-04       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.